CSL has named Deborah Waterhouse, a British pharmaceutical executive who helped negotiate Australian medicines policy more ...
Telix Pharmaceuticals has reaffirmed that it will pass US$1 billion in revenue and other income this year. Its third-quarter ...
GLP-1 medicines were a key part of the update. Sigma said the business was still growing even though the first sales boost from these medicines is now in the base.
Algorae Pharmaceuticals has signed two agreements with Mumbai-based manufacturer Umedica Laboratories. Together, they give ...
In a discussion with BioPharmaDispatch, Professor Hill said the starting point was a set of management questions she put to ...
A year ago, Professor Richard Scolyer, who was living with glioblastoma, stood in Parliament House in Canberra and urged ...
Up to 600,000 Australian children live with a rare disease or a profound or severe disability, and for about half of them, ...
Albert Hirschman argued that voice works only when exit is credible. For 80 years, the pharmaceutical industry has had voice ...
Medicines Australia has added two new directors to its board. Anne Harris of Novartis and Ed Hollywood of Boehringer ...
The withdrawal follows a series of regulatory actions overseas centred on the drug's pivotal ADVOCATE trial and a growing liver-injury safety signal.
New Zealand's National Party has put medicines back at the centre of its health campaign, promising an additional NZ$604 million for Pharmac if it returns to government at the 7 November election. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results